サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1387799

止瀉薬の世界市場レポート 2024年

Antidiarrheals Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
止瀉薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

止瀉剤の市場規模は近年着実に成長しています。2023年の37億6,000万米ドルから2024年には38億9,000万米ドルまで、CAGR3.3％で成長します。この期間に見られた成長は、疾病の流行、世界の健康への取り組み、高齢化、医薬品の革新、患者の意識の向上など、いくつかの重要な要因によるものです。

北米は、2023年の止瀉薬市場において最大の地域でした。止瀉薬市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 止瀉薬市場の特徴

第3章 止瀉薬市場の動向と戦略

第4章 止瀉薬市場 - マクロ経済シナリオ

第5章 世界の止瀉薬市場規模と成長

  • 世界の止瀉薬市場促進要因と制約
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の止瀉薬市場規模実績と成長、2018年～2023年
  • 世界の止瀉薬市場規模と成長予測、2023年～2028年、2033年

第6章 止瀉薬市場セグメンテーション

  • 世界の止瀉薬市場、タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • OTC医薬品（一般用医薬品）
  • 処方薬
  • 世界の止瀉薬市場、薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 粘膜保護剤
  • 運動性調節薬
  • 世界の止瀉薬市場、用途別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 成人
  • 小児

第7章 止瀉薬市場の地域および国分析

  • 世界の止瀉薬市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界の止瀉薬市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋の止瀉薬市場

  • 概要
  • 地域情報、COVID-19症の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第9章 中国の止瀉薬市場

第10章 インドの止瀉薬市場

第11章 日本の止瀉薬市場

第12章 オーストラリアの止瀉薬市場

第13章 インドネシアの止瀉薬市場

第14章 韓国の止瀉薬市場

第15章 西欧の止瀉薬市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第16章 英国の止瀉薬市場

第17章 ドイツの止瀉薬市場

第18章 フランスの止瀉薬市場

第19章 イタリアの止瀉薬市場

第20章 スペインの止瀉薬市場

第21章 東欧の止瀉薬市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第22章 ロシアの止瀉薬市場

第23章 北米の止瀉薬市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第24章 米国の止瀉薬市場

第25章 カナダの止瀉薬市場

第26章 南米の止瀉薬市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第27章 ブラジルの止瀉薬市場

第28章 中東の止瀉薬市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第29章 アフリカの止瀉薬市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年

第30章 止瀉薬市場の競合情勢と企業プロファイル

  • 止瀉薬市場の競合情勢
  • 止瀉薬市場の企業プロファイル
    • GlaxoSmithKline plc.
    • Actelion Pharmaceuticals Ltd.
    • Perrigo Company Plc.
    • Lupin Limited
    • Glenmark Pharmaceuticals Limited

第31章 世界の止瀉薬市場の競合ベンチマーキング

第32章 世界の止瀉薬市場競争ダッシュボード

第33章 止瀉薬市場における主要な合併と買収

第34章 止瀉薬市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r9041

“Antidiarrheals Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antidiarrheals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antidiarrheals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The antidiarrheals market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Class: Mucosal Protectants; Motility Modifying Drugs
  • 2) By Application: Adults; Childrens
  • 3) By Type: OTC drugs; Prescription Drugs
  • Companies Mentioned: GlaxoSmithKline plc; Actelion Pharmaceuticals Ltd (a subsidiary of Johnson & Johnson); Perrigo Company plc; Lupin Limited; Glenmark Pharmaceuticals Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Antidiarrheal drugs are medications designed to alleviate the symptoms of diarrhea, particularly the frequent passage of watery and loose stools. These drugs can be categorized into three primary groups based on their chemical or functional properties including adsorbents, antimotility agents, and bacterial replacements (probiotics).

The two major classes of antidiarrheal drugs are mucosal protectants and motility-modifying drugs. Mucosal protectants are drugs that serve to protect the stomach's mucosal lining from the corrosive effects of gastric acid and are commonly used in the treatment of peptic ulcers. These agents are available in various forms, including over-the-counter (OTC) medications and prescription drugs, suitable for both adults and children.

The antidiarrheal drugs market research report is one of a series of new reports from The Business Research Company that provides antidiarrheal drugs market statistics, including antidiarrheal drugs industry global market size, regional shares, competitors with antidiarrheal drugs market share, detailed antidiarrheal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the antidiarrheal drugs industry. This antidiarrheal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antidiarrhoeals market size has grown steadily in recent years. It will grow from $3.76 billion in 2023 to $3.89 billion in 2024 at a compound annual growth rate (CAGR) of 3.3%. The growth observed during the historical period can be attributed to several key factors, including the prevalence of diseases, global health initiatives, an aging population, pharmaceutical innovation, and increased patient awareness.

The antidiarrhoeals market size is expected to see steady growth in the next few years. It will grow to $4.41 billion in 2028 at a compound annual growth rate (CAGR) of 3.2%. The anticipated growth in the forecast period can be attributed to various factors, including the expansion of emerging markets, environmental considerations, global health challenges, epidemiology, and the burden of disease. Additionally, significant trends in this forecast period encompass the rise of digital health and telemedicine, a shift toward patient-centric care, the popularity of self-care and over-the-counter (OTC) products, the advancement of personalized medicine, and the progress in biotechnology.

The increasing number of diarrhea cases plays a significant role in driving the growth of the antidiarrheal drug market. As reported by UNICEF, diarrhea stands as the second leading cause of death among children under 5 years of age, responsible for claiming the lives of 760,000 children annually. The growing prevalence of diarrhea underscores the heightened demand for antidiarrheal drugs in the market.

The growing prevalence of gastroparesis is anticipated to drive the expansion of the antidiarrheal market. Gastroparesis is a medical condition characterized by the slowing down or delay of food movement from the stomach to the small intestine. This condition can be triggered by various factors, including hypothyroidism, autoimmune diseases, injury to the vagus nerve, and viral stomach infections. Antidiarrheal medications are used to manage gastroparesis and alleviate symptoms such as cramps, bloating, and pressure. For example, in 2021, a research study published by Practice Update, a Netherlands-based online publisher of research articles, reported that the overall prevalence rate of gastroparesis in the US was 267.7 cases per 100,000 individuals, with a prevalence rate of definite gastroparesis at 21.5 cases per 100,000 persons. This increasing prevalence of gastroparesis is expected to be a driving factor in the growth of the antidiarrheal market.

The increased utilization of biologic medicines serves as a constraint for the antidiarrheal market. Biologics are medications derived from living organisms, including humans, animals, or other microorganisms, utilizing biotechnology. They are composed of proteins, sugars, nucleic acids, or a combination of these substances. Biologics have gained preference over traditional chemical drugs due to their ability to target previously inaccessible areas using small-molecule therapies. This shift towards biologics is limiting the growth of the antidiarrheal drugs market. For instance, in the treatment of conditions like Crohn's Disease, antidiarrheal medications were previously employed. However, with the emergence of biologics, the demand for antidiarrheal drugs has diminished as they are being used to address the underlying disease more effectively.

Prominent companies operating in the antidiarrheal drug market are actively engaging in mergers and acquisitions with other players in the industry as a strategic approach to expand their market reach and increase their market share. Such mergers and acquisitions allow companies to enhance their market presence, diversify their product portfolios, and gain access to new technologies and capabilities. For example, GlaxoSmithKline's agreement to acquire Novartis AG's 36.5% stake in the consumer healthcare business for $13 billion is a notable move aimed at expanding their presence in the market. This demonstrates a common industry strategy to strengthen and grow their positions through strategic alliances and business combinations.

Major companies in the antidiarrheal drug market are actively involved in product innovation to enhance their profitability. One such innovation is the development of Nitazoxanide Tablets, which are prescribed for the treatment of diarrhea caused by specific parasitic infections in the gastrointestinal tract. For example, in March 2021, Lupin Limited, a US-based pharmaceutical company, introduced the authorized generic version of Alinia (nitazoxanide) Tablets. Nitazoxanide Tablets are indicated for managing diarrhea resulting from Giardia lamblia or Cryptosporidium parvum infections in patients aged 12 years and above. This type of innovation is aimed at addressing specific healthcare needs and expanding the product portfolio, thus contributing to increased profitability in the antidiarrheal drug market.

In September 2021, AzurRx BioPharma, a US-based biotechnology company, completed the acquisition of First Wave Bio, Inc. for a total of $229 million. This strategic acquisition served to diversify AzurRx's portfolio by adding a range of new treatments for inflammatory bowel disease, all of which are based on the use of niclosamide. First Wave Bio, Inc. is a biotech company also based in the United States.

Major companies operating in the antidiarrhoeals market include GlaxoSmithKline PLC, Actelion Pharmaceuticals Ltd (a subsidiary of Johnson & Johnson), Perrigo Company PLC, Lupin Limited, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Pfizer Inc., The Procter & Gamble Company, Sanofi-aventis U.S. LLC, Bayer AG, Johnson & Johnson, Novartis International AG, The Kroger Co., Harmon Stores Inc., Great Lakes Wholesale Marketing and Sales Inc., Geri-Care Pharmaceuticals Corp., Fred's Inc., Dolgen Corporation, CVS Pharmacy Inc., American Sales Company, Cardinal Health Inc., Bedrock LLC, Greenbrier International Inc., Good Neighbor Pharmacy, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Cipla Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd.

North America was the largest region in the antidiarrhoeals market in 2023. The regions covered in the antidiarrhoeals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the antidiarrhoeals market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The antidiarrheal drugs market consists of sales loperamide hydrochloride, Bismuth subsalicylate, Pepto Bismol and Imodium. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Antidiarrheals Market Characteristics

3. Antidiarrheals Market Trends And Strategies

4. Antidiarrheals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Antidiarrheals Market Size and Growth

  • 5.1. Global Antidiarrheals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Antidiarrheals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Antidiarrheals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antidiarrheals Market Segmentation

  • 6.1. Global Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • OTC Drugs (Over-The-Counter)
  • Prescription Drugs
  • 6.2. Global Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Mucosal Protectants
  • Motility Modifying Drugs
  • 6.3. Global Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adults
  • Children

7. Antidiarrheals Market Regional And Country Analysis

  • 7.1. Global Antidiarrheals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Antidiarrheals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antidiarrheals Market

  • 8.1. Asia-Pacific Antidiarrheals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antidiarrheals Market

  • 9.1. China Antidiarrheals Market Overview
  • 9.2. China Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antidiarrheals Market

  • 10.1. India Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antidiarrheals Market

  • 11.1. Japan Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antidiarrheals Market

  • 12.1. Australia Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antidiarrheals Market

  • 13.1. Indonesia Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antidiarrheals Market

  • 14.1. South Korea Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antidiarrheals Market

  • 15.1. Western Europe Antidiarrheals Market Overview
  • 15.2. Western Europe Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antidiarrheals Market

  • 16.1. UK Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antidiarrheals Market

  • 17.1. Germany Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antidiarrheals Market

  • 18.5. France Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antidiarrheals Market

  • 19.9. Italy Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antidiarrheals Market

  • 20.13. Spain Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antidiarrheals Market

  • 21.1. Eastern Europe Antidiarrheals Market Overview
  • 21.2. Eastern Europe Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antidiarrheals Market

  • 22.1. Russia Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antidiarrheals Market

  • 23.1. North America Antidiarrheals Market Overview
  • 23.2. North America Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antidiarrheals Market

  • 24.1. USA Antidiarrheals Market Overview
  • 24.2. USA Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antidiarrheals Market

  • 25.1. Canada Antidiarrheals Market Overview
  • 25.2. Canada Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antidiarrheals Market

  • 26.1. South America Antidiarrheals Market Overview
  • 26.2. South America Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antidiarrheals Market

  • 27.1. Brazil Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antidiarrheals Market

  • 28.1. Middle East Antidiarrheals Market Overview
  • 28.2. Middle East Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antidiarrheals Market

  • 29.1. Africa Antidiarrheals Market Overview
  • 29.2. Africa Antidiarrheals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Antidiarrheals Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Antidiarrheals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antidiarrheals Market Competitive Landscape And Company Profiles

  • 30.1. Antidiarrheals Market Competitive Landscape
  • 30.2. Antidiarrheals Market Company Profiles
    • 30.2.1. GlaxoSmithKline plc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Actelion Pharmaceuticals Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Perrigo Company Plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lupin Limited
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Glenmark Pharmaceuticals Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Antidiarrheals Market Competitive Benchmarking

32. Global Antidiarrheals Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Antidiarrheals Market

34. Antidiarrheals Market Future Outlook and Potential Analysis

  • 34.1 Antidiarrheals Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Antidiarrheals Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Antidiarrheals Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer